• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Jun27
Distribution Plan(EST)

Cash dividend 0.6355 USD

Jun23
Distribution Plan(EST)

Cash dividend 0.6355 USD

Distribution Plan(EST)

Cash dividend 0.6355 USD

View More

Event Tracking

Nov24
Wall Street Analysts Maintain Buy Rating for Structure Therapeutics
19:37
Nov20
Structure Therapeutics Reaffirmed With Buy Rating, Price Target Set at $100
12:57
Nov7
Stifel Nicolaus analyst maintains buy rating on Structure Therapeutics
15:52
Structure Therapeutics released FY2025 9 Months Earnings on November 6, 2025 (EST) with actual revenue of USD 0 and EPS of USD -3.0115
04:00
Structure Therapeutics released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.1414 (forecast USD -0.3677)
04:00
Oct30
Patrick Dolezal Maintains Buy Rating for Structure Therapeutics
11:38